Atuka will attend the AAT-AD/PD Focus Meeting, 15th-18th March, Turin, Italy. Please see us at the following poster:
“NYX-458, A NMDA RECEPTOR MODULATOR, IMPROVES COGNITIVE DEFICITS IN A NON-HUMAN PRIMATE MPTP MODEL OF COGNITIVE IMPAIRMENT IN PARKINSON’S DISEASE”
We look forward to meeting you and discussing the services that we offer in Parkinson’s disease, chemistry, drug development, cognitive disorders and primate services.
Description & References: